Armata Pharmaceuticals (ARMP) Receivables - Net (2013 - 2023)

Armata Pharmaceuticals has disclosed Receivables - Net across 9 years of filings, most recently posting $300000.0 for Q4 2023.

• Receivables - Net for Q4 2023 came in at $300000.0, down 84.5% year-over-year; the trailing twelve-month figure through Dec 2023 was $300000.0 (down 84.5% YoY), and the FY2023 annual result was $300000.0, down 84.5% from the prior year.
• Receivables - Net came in at $300000.0 for Q4 2023 at Armata Pharmaceuticals, down from $1.3 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $3.0 million in Q4 2021 to a low of $300000.0 in Q4 2023.
• The 4-year median for Receivables - Net is $1.2 million (2022), against an average of $1.3 million.
• Across the five-year window, Receivables - Net surged 432.8% in 2021 and slumped 84.5% in 2023, its largest moves.
• Armata Pharmaceuticals' Receivables - Net stood at $561000.0 in 2020, then soared by 432.8% to $3.0 million in 2021, then plunged by 35.23% to $1.9 million in 2022, then plunged by 84.5% to $300000.0 in 2023.
• The last three Receivables - Net figures came in at $300000.0 (Q4 2023), $1.3 million (Q1 2023), and $1.9 million (Q4 2022), per Business Quant data.